How alcohol affects inflammation and Alzheimer's disease
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
This study looks at how drinking too much alcohol might affect the development and worsening of Alzheimer's disease, especially by causing inflammation in the brain, and it hopes to find new ways to help people with a history of heavy drinking who are at risk for Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10906811 on NIH RePORTER |
What this research studies
This research investigates the impact of excessive alcohol consumption on the development and progression of Alzheimer's disease (AD). It focuses on understanding how alcohol-induced neuroinflammation, particularly through the activation of the NLRP3 inflammasome, influences AD pathology. By using mouse models of AD, the study aims to identify critical molecular pathways that could serve as therapeutic targets for treating or preventing AD in individuals with a history of heavy alcohol use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of heavy alcohol consumption who are also experiencing symptoms of Alzheimer's disease.
Not a fit: Patients who do not consume alcohol and do not have Alzheimer's disease may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for patients with Alzheimer's disease who consume alcohol.
How similar studies have performed: Previous research has shown that targeting neuroinflammation can be beneficial in Alzheimer's disease, suggesting that this approach may yield promising results.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Szabo, Gyongyi — Beth Israel Deaconess Medical Center
- Study coordinator: Szabo, Gyongyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.